Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Planta ; 251(6): 104, 2020 May 07.
Article in English | MEDLINE | ID: mdl-32382847

ABSTRACT

MAIN CONCLUSION: An artificial lignified cell wall was synthesized in three steps: (1) isolation of microfibrillar network; (2) localization of peroxidase through immunoreaction; and (3) polymerization of DHP to lignify the cell wall. Artificial woody cell wall synthesis was performed following the three steps along with the actual formation in nature using cellulose microfibrils extracted from callus derived from Cryptomeria japonica. First, we constructed a polysaccharide network on a transmission electron microscopy (TEM) grid. The preparation method was optimized by chemical treatment, followed by mechanical fibrillation to create a microfibrillated network. Morphology was examined by TEM, and chemical characterization was by Fourier transform infrared (FTIR) spectroscopy. Second, we optimized the process to place peroxidase on the microfibrils via an immunoreaction technique. Using a xyloglucan antibody, we could ensure that gold particles attached to the secondary antibodies were widely and uniformly localized along with the microfibril network. Third, we applied the peroxidase attached to secondary antibodies and started to polymerize the lignin on the grid by simultaneously adding coniferyl alcohol and hydrogen peroxide. After 30 min of artificial lignification, TEM observation showed that lignin-like substances were deposited on the polysaccharide network. In addition, FTIR spectra revealed that the bands specific for lignin had increased, demonstrating the successful artificial formation of woody cell walls. This approach may be useful for studying woody cell wall formation and for producing made-to-order biomaterials.


Subject(s)
Cell Wall/ultrastructure , Cellulose/metabolism , Cryptomeria/chemistry , Lignin/metabolism , Microfibrils/metabolism , Peroxidase/metabolism , Catalysis , Cell Wall/chemistry , Cells, Cultured , Cellulose/ultrastructure , Cryptomeria/enzymology , Hydrogen Peroxide/metabolism , Microfibrils/ultrastructure , Microscopy, Electron, Transmission , Plant Proteins/metabolism , Polysaccharides/metabolism , Spectroscopy, Fourier Transform Infrared , Wood
2.
Appl Biochem Biotechnol ; 188(4): 1066-1076, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30783948

ABSTRACT

A method for the high-throughput analysis of the relative lignin contents of Cryptomeria japonica samples over a wide concentration range (3-73%), independent of the type of chemical pretreatment, was developed by using Fourier transform infrared spectroscopy. First, the assignments of the infrared absorbance related to lignin were reviewed. Then, various chemical treatments, including alkaline, acid, and hydrothermal processes, and a sodium chlorite oxidation treatment, were performed to prepare samples containing a wide range of different lignin contents. Principal component analysis indicated high variability among the chemical treatments in terms of the corresponding lignin contents as well as the resulting changes in the chemical structure of hemicellulose; this conclusion was supported by the loading vectors. The intensity of the key band of lignin at 1508 cm-1 was calculated using the absorbance at 2900 cm-1 as a reference; a reliable calibration curve with an R2 of 0.968 was obtained independent of the chemical treatment performed. This simple and rapid method for determining the lignin content is expected to be widely applicable for optimizing bioethanol production, as well as monitoring biomass degradation processes.


Subject(s)
Cryptomeria/metabolism , Lignin/chemistry , Biomass , Principal Component Analysis , Spectroscopy, Fourier Transform Infrared/methods
3.
J Antibiot (Tokyo) ; 70(9): 929-936, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28676715

ABSTRACT

Allantopyrone A is a fungal metabolite that uniquely possesses two α,ß-unsaturated carbonyl moieties. We recently reported that allantopyrone A inhibited the nuclear factor-κB (NF-κB) signaling pathway induced by tumor necrosis factor (TNF)-α in human lung carcinoma A549 cells. In the present study, the mechanism by which allantopyrone A inhibits the TNF-α-induced signaling pathway was investigated in more detail. Allantopyrone A blocked extensive modifications to receptor-interacting protein 1 (RIP1) in the TNF receptor 1 (TNF-R1) complex. Allantopyrone A augmented the high-MW bands of TNF-R1, TNF receptor-associated factor 2, RIP1, the NF-κB subunit RelA and inhibitor of NF-κB kinase ß in A549 cells, suggesting that it binds to and promotes the crosslinking of these proteins. The extracellular cysteine-rich domains of TNF-R1 were crosslinked by allantopyrone A more preferentially than its intracellular portion. The present results demonstrate that allantopyrone A interferes with multiple components of the TNF-R1 complex and blocks RIP1 modifications in the TNF-α-induced NF-κB signaling pathway.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , HSP90 Heat-Shock Proteins/antagonists & inhibitors , Pyrones/pharmacology , Receptor-Interacting Protein Serine-Threonine Kinases/antagonists & inhibitors , Receptors, Tumor Necrosis Factor, Type I/antagonists & inhibitors , Signal Transduction/drug effects , Tumor Necrosis Factor-alpha/antagonists & inhibitors , A549 Cells , Cysteine/chemistry , Cysteine/metabolism , Genes, Reporter/drug effects , HEK293 Cells , HSP90 Heat-Shock Proteins/chemistry , HSP90 Heat-Shock Proteins/genetics , HSP90 Heat-Shock Proteins/metabolism , Humans , Molecular Weight , NF-KappaB Inhibitor alpha/antagonists & inhibitors , NF-KappaB Inhibitor alpha/chemistry , NF-KappaB Inhibitor alpha/metabolism , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Interaction Domains and Motifs , Protein Multimerization/drug effects , Protein Processing, Post-Translational/drug effects , Receptor-Interacting Protein Serine-Threonine Kinases/chemistry , Receptor-Interacting Protein Serine-Threonine Kinases/genetics , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Receptors, Tumor Necrosis Factor, Type I/chemistry , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor, Type I/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , TNF Receptor-Associated Factor 2/antagonists & inhibitors , TNF Receptor-Associated Factor 2/chemistry , TNF Receptor-Associated Factor 2/metabolism , Transcription Factor RelA/antagonists & inhibitors , Transcription Factor RelA/chemistry , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/chemistry , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
4.
Biol Pharm Bull ; 38(6): 941-6, 2015.
Article in English | MEDLINE | ID: mdl-26027837

ABSTRACT

Irciniastatin A is a pederin-type marine product that potently inhibits translation. We have recently shown that irciniastatin A induces ectodomain shedding of tumor necrosis factor (TNF) receptor 1 with slower kinetics than other translation inhibitors. In human lung carcinoma A549 cells, irciniastatin A induced a marked and sustained activation of extracellular signal-regulated kinase (ERK) and induced little activation of p38 mitogen-activated protein (MAP) kinase and c-Jun N-terminal kinase (JNK). Moreover, the TNF receptor 1 shedding induced by irciniastatin A was blocked by the MAP kinase/ERK kinase inhibitor U0126, but not by the p38 MAP kinase inhibitor SB203580 or the JNK inhibitor SP600125. Thus unlike other translation inhibitors that trigger ribotoxic stress response, our results show that irciniastatin A is a unique translation inhibitor that induces a potent and sustained activation of the ERK pathway, and thereby promotes the ectodomain shedding of TNF receptor 1 in A549 cells.


Subject(s)
Antineoplastic Agents/therapeutic use , Biological Products/therapeutic use , Coumarins/therapeutic use , Extracellular Signal-Regulated MAP Kinases/metabolism , Lung Neoplasms/drug therapy , Porifera/chemistry , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antineoplastic Agents/pharmacology , Biological Products/pharmacology , Cell Line, Tumor , Coumarins/pharmacology , Enzyme Inhibitors/pharmacology , JNK Mitogen-Activated Protein Kinases/metabolism , Lung Neoplasms/metabolism , NF-kappa B/metabolism , Signal Transduction , TNF Receptor-Associated Factor 1/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
6.
Eur J Pharmacol ; 701(1-3): 144-51, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23357557

ABSTRACT

Trichothecene mycotoxins are known to inhibit eukaryotic translation and to trigger the ribotoxic stress response, which regulates gene expression via the activation of the mitogen-activated protein (MAP) kinase superfamily. In this study, we found that deoxynivalenol induced the ectodomain shedding of tumor necrosis factor (TNF) receptor 1 (TNFRSF1A) and thereby inhibited the TNF-α-induced signaling pathway. In human lung carcinoma A549 cells, deoxynivalenol and 3-acetyldeoxynivalenol inhibited the expression of intercellular adhesion molecule-1 (ICAM-1) induced by TNF-α more strongly than that induced by interleukin 1α (IL-1α), whereas T-2 toxin and verrucarin A exerted nonselective inhibitory effects. Deoxynivalenol and 3-acetyldeoxynivalenol also inhibited the nuclear factor κB (NF-κB) signaling pathway induced by TNF-α, but not that induced by IL-1α. Consistent with these findings, deoxynivalenol and 3-acetyldeoxynivalenol induced the ectodomain shedding of TNF receptor 1 by TNF-α-converting enzyme (TACE), also known as a disintegrin and metalloproteinase 17 (ADAM17). In addition to the TACE inhibitor TAPI-2, the MAP kinase or extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor U0126 and the p38 MAP kinase inhibitor SB203580, but not the c-Jun N-terminal kinase (JNK) inhibitor SP600125, suppressed the ectodomain shedding of TNF receptor 1 induced by deoxynivalenol and reversed its selective inhibition of TNF-α-induced ICAM-1 expression. Our results demonstrate that deoxynivalenol induces the TACE-dependent ectodomain shedding of TNF receptor 1 via the activation of ERK and p38 MAP kinase, and thereby inhibits the TNF-α-induced NF-κB signaling pathway.


Subject(s)
NF-kappa B/metabolism , Receptors, Tumor Necrosis Factor/chemistry , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction/drug effects , Trichothecenes/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Cell Line, Tumor , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Expression Regulation/drug effects , Humans , Intercellular Adhesion Molecule-1/metabolism , Interleukin-1alpha/pharmacology , Mycotoxins/toxicity , Protein Structure, Tertiary , Trichothecenes/toxicity , p38 Mitogen-Activated Protein Kinases/metabolism
7.
Biosci Biotechnol Biochem ; 76(12): 2360-3, 2012.
Article in English | MEDLINE | ID: mdl-23221713

ABSTRACT

(11S)-2α-Bromo-3-oxoeudesmano-12,6α-lactone, designated santonin-related compound 2 (SRC2), only weakly affected IκBα degradation after tumor necrosis factor-α (TNF-α) stimulation, but strongly blocked the nuclear translocation of nuclear factor κB (NF-κB) subunit p65. Replacement of Cys-38 of p65 with serine abolished the inhibitory effect of SRC2 on this TNF-α-induced nuclear translocation. These results indicate that SRC2 inhibits the nuclear translocation of p65 by targeting Cys-38.


Subject(s)
Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cysteine , Santonin/analogs & derivatives , Santonin/pharmacology , Signal Transduction/drug effects , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Active Transport, Cell Nucleus/drug effects , Cell Line, Tumor , Humans , Transcription Factor RelA/chemistry
8.
Bioorg Med Chem Lett ; 22(1): 207-11, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-22153345

ABSTRACT

Inflammatory cytokines, such as interleukin-1α (IL-1α) and tumor necrosis factor-α (TNF-α), induce the intracellular signaling pathway leading to the activation of nuclear factor κB (NF-κB). A series of eudesmane-type sesquiterpene lactones possessing an α-methylene γ-lactone group and/or an α-bromo ketone group were synthesized and evaluated for their inhibitory effects on the NF-κB-dependent gene expression and signaling pathway. Our present study reveals that eudesmane-type α-methylene γ-lactones and α-bromo ketones inhibit multiple steps in the NF-κB signaling pathway induced by IL-1α and TNF-α.


Subject(s)
Cytokines/metabolism , Lactones/chemistry , NF-kappa B/metabolism , Sesquiterpenes, Eudesmane/pharmacology , Sesquiterpenes/chemistry , Algorithms , Cell Line, Tumor , Chemistry, Pharmaceutical/methods , Dimerization , Drug Design , Humans , Inflammation/drug therapy , Inhibitory Concentration 50 , Intercellular Adhesion Molecule-1/biosynthesis , Interleukin-1alpha/metabolism , Ketones/chemistry , Models, Chemical , Signal Transduction , Time Factors , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...